Title : Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study - McGill_2013_Diabetes.Care_36_237 |
Author(s) : McGill JB , Sloan L , Newman J , Patel S , Sauce C , von Eynatten M , Woerle HJ |
Ref : Diabetes Care , 36 :237 , 2013 |
Abstract : McGill_2013_Diabetes.Care_36_237 |
ESTHER : McGill_2013_Diabetes.Care_36_237 |
PubMedSearch : McGill_2013_Diabetes.Care_36_237 |
PubMedID: 23033241 |
Title : Liraglutide: effects beyond glycaemic control in diabetes treatment - McGill_2010_Int.J.Clin.Pract.Suppl__28 |
Author(s) : McGill JB |
Ref : Int J Clin Pract Suppl , :28 , 2010 |
Abstract : McGill_2010_Int.J.Clin.Pract.Suppl__28 |
ESTHER : McGill_2010_Int.J.Clin.Pract.Suppl__28 |
PubMedSearch : McGill_2010_Int.J.Clin.Pract.Suppl__28 |
PubMedID: 20887302 |
Title : Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes - McGill_2009_Postgrad.Med_121_46 |
Author(s) : McGill JB |
Ref : Postgrad Med , 121 :46 , 2009 |
Abstract : McGill_2009_Postgrad.Med_121_46 |
ESTHER : McGill_2009_Postgrad.Med_121_46 |
PubMedSearch : McGill_2009_Postgrad.Med_121_46 |
PubMedID: 19179813 |
Title : The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes - Triplitt_2007_J.Manag.Care.Pharm_13_S2 |
Author(s) : Triplitt C , McGill JB , Porte D, Jr. , Conner CS |
Ref : J Manag Care Pharm , 13 :S2 , 2007 |
Abstract : Triplitt_2007_J.Manag.Care.Pharm_13_S2 |
ESTHER : Triplitt_2007_J.Manag.Care.Pharm_13_S2 |
PubMedSearch : Triplitt_2007_J.Manag.Care.Pharm_13_S2 |
PubMedID: 18062735 |